Therapeutics Supplements and Botanicals
RRM Academy Synopsis
In 55 women, vitamin B6 may ease some premenstrual symptoms
A 1987 double-blind controlled trial of 55 women with moderate to severe premenstrual mood changes found that vitamin B6 may ease dizziness, vomiting and behavioral symptoms before menstruation. In these women, a significant amount of physical and emotional symptoms still remained. The authors urge caution about possible toxicity.
Key Findings
- Analysis of covariance suggested that vitamin B6 may improve autonomic symptoms such as dizziness and vomiting, and behavioral changes such as poor performance and reduced social activity.
- Even so, the women studied still had a significant amount of physical and emotional symptoms in the days before their periods.
- The trial enrolled 55 women who reported moderate to severe premenstrual mood changes, and researchers randomly assigned them to vitamin B6 or a placebo taken daily for two months.
- Before treatment began, each woman kept a daily home symptom diary for one month, and she continued the diary during treatment.
Interpretation
This synopsis rests on the published abstract alone. The study is a randomized, double-blind, placebo-controlled trial of women with moderate to severe premenstrual mood changes. The authors phrase the benefit with the word "may" and point to recent reports of potentially toxic effects of low vitamin B6 doses.
RRM Context
Premenstrual symptoms follow the timing of the cycle, and the daily diaries in this trial recorded when the women's symptoms occurred. Restorative reproductive medicine treats such symptoms as signals of underlying hormonal function that merit investigation. A supplement trial that leaves much of the symptom burden in place keeps the question of cause open.
Abstract
A double-blind controlled study of the effects of vitamin B6 supplementation on premenstrual symptoms was conducted. Fifty-five women who reported moderate to severe premenstrual mood changes participated in the study. Symptoms were monitored prospectively through daily home record-keeping over a one-month baseline period followed by two months of treatment. Subjects were randomly assigned to receive daily supplements of 150 mg of vitamin B6 or placebo over the entire two-month treatment period. Analysis of covariance suggested that even though vitamin B6 may improve premenstrual symptoms related to autonomic reactions (eg, dizziness and vomiting) and behavioral changes (eg, poor performance and decreased social activities), a significant amount of physical and affective symptomatology remained during the premenstrual phase. In light of recently reported, potentially toxic effects of low doses of vitamin B6, our results call for caution in using this therapy for premenstrual symptoms.
Topics
Keywords
Adult, Clinical Trials As Topic, Double-Blind Method, Female, Humans, Premenstrual Syndrome/drug Therapy/physiopathology, Pyridoxine/therapeutic Use, Pyridoxine


